Video: Campaigner Dr Ben Goldacre calls for GP support on trial transparency

The lack of transparency over clinical trial data harms patient care as much as medical incompetence, Dr Ben Goldacre has warned.

The epidemiologist and author of Bad Pharma urged GPs to support evidence-based medicine by demanding clinical trials were registered and results published in full, and he called on the college to ‘take a stand’ on the issue.

In an energetic speech at the RCGP conference yesterday, Dr Goldacre, who campaigns for clinical trial transparency, gave several examples where full trial results for commonly prescribed drugs had been withheld.

He said current systems to register trials and publish full results were not working.

The ‘abstract statistics’ behind evidence-based medicine were ‘not about lines on a graph, they’re not about numbers on a page, they’re about real world avoidable suffering and death’, he said.

‘We, as people who understand evidence-based medicine, who understand epidemiology, I think need to raise our game. We need to recognise that, where there are these things that lead to people making wrong treatments, we need to fix them.

‘Upstream, where people withhold the results of clinical trials from the medical and academic community, that is research misconduct because it has a negative impact on patient care, as sure as if you were an incompetent physician, there and then in front of your patient.’

Dr Goldacre said despite recent pledges to open up trial data, such as the European Medicines Agency’s promise to allow access to trial data from 2014, the problem had not been fixed, and ‘it needs to be fixed’.

In July this year, the BMA passed a motion that withholding the results of clinical trials is research misconduct. Dr Goldacre called on the college to join this position. ‘I think the RCGP should take a really robust stance on this, stand up and say: withholding clinical trial results is research misconduct, and it’s not tolerable for our members.’

Dr Goldacre added: ‘We can’t practice evidence-based medicine in an environment in which half the trials have been withheld from doctors and patients and academics.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs plan drive-through flu clinics amid COVID-19 safety fears

GPs plan drive-through flu clinics amid COVID-19 safety fears

GP practices are planning drive-through flu clinics to maximise uptake of jabs during...

£20,000 golden hello scheme could trigger hidden costs, accountants warn

£20,000 golden hello scheme could trigger hidden costs, accountants warn

A government scheme offering £20,000 golden hellos for new partners could trigger...

GPs demand release of COVID funding as practices face 'severe financial disruption'

GPs demand release of COVID funding as practices face 'severe financial disruption'

GP practices are facing ‘severe financial disruption’ and could go bankrupt without...

£20,000 golden hello scheme for new GP partners opens from 1 July

£20,000 golden hello scheme for new GP partners opens from 1 July

GPs taking up partnership roles for the first time can apply for a £20,000 golden...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

When should GPs disclose information about a patient with a serious communicable disease?

When should GPs disclose information about a patient with a serious communicable disease?

MDU medico-legal adviser Dr Ellie Mein offers advice on how to handle situations...